James Andrea S.

CIK 00020270101 companyIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0002027010

Recent Transactions

14 trades

Tax Payment
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2025-10-31$6.01/sh−12,175→ 189,056 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2025-10-31+50,000→ 201,231 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2025-10-31−50,000→ 50,000 total
Exercise/Conversion
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2025-10-31+50,000→ 201,231 total
Disposition to Issuer
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2025-10-31+50,000→ 50,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2025-09-28+235,000→ 235,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2025-03-26+113,207→ 113,207 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2025-02-07$2.05/sh+97,561→ 151,231 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2024-12-05$2.29/sh+20,000→ 53,670 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2024-10-11+100,000→ 100,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Options to Purchase Common Stock
2024-10-11+200,000→ 200,000 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock, no par value
2024-10-02$2.97/sh+33,670→ 33,670 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Option to Purchase Common Stock
2024-06-20+200,000→ 200,000 total
Award
Insight Molecular Diagnostics Inc.$IMDX
Restricted Stock Units
2024-06-20+100,000→ 300,000 total

Companies

Insight Molecular Diagnostics Inc.
Chief Financial Officer
$IMDX

Recent Filings

Address

C/O ONCOCYTE CORPORATION 15 CUSHING

IRVINE, CA, 92618

View on SEC.gov